ABBV-932
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for ABBV-932, covering 2024-07-01 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder [Phase 2]